131 related articles for article (PubMed ID: 32786546)
21. Exploring the possible metabolism mediated interaction of Glycyrrhiza glabra extract with CYP3A4 and CYP2D6.
Pandit S; Ponnusankar S; Bandyopadhyay A; Ota S; Mukherjee PK
Phytother Res; 2011 Oct; 25(10):1429-34. PubMed ID: 21351298
[TBL] [Abstract][Full Text] [Related]
22. Interactions of Papua New Guinea medicinal plant extracts with antiretroviral therapy.
Larson EC; Hathaway LB; Lamb JG; Pond CD; Rai PP; Matainaho TK; Piskaut P; Barrows LR; Franklin MR
J Ethnopharmacol; 2014 Sep; 155(3):1433-40. PubMed ID: 25138353
[TBL] [Abstract][Full Text] [Related]
23. High-throughput screening of inhibitory effects of Bo-yang-hwan-o-tang on human cytochrome P450 isoforms in vitro using UPLC/MS/MS.
Lee M; Park J; Lim MS; Seong SJ; Lee J; Seo JJ; Park YK; Lee HW; Yoon YR
Anal Sci; 2012; 28(12):1197-201. PubMed ID: 23232241
[TBL] [Abstract][Full Text] [Related]
24. Exploration of catalytic properties of CYP2D6 and CYP3A4 through metabolic studies of levorphanol and levallorphan.
Bonn B; Masimirembwa CM; Castagnoli N
Drug Metab Dispos; 2010 Jan; 38(1):187-99. PubMed ID: 19797609
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P450 inhibitory potential and RP-HPLC standardization of trikatu--a Rasayana from Indian Ayurveda.
Harwansh RK; Mukherjee K; Bhadra S; Kar A; Bahadur S; Mitra A; Mukherjee PK
J Ethnopharmacol; 2014 May; 153(3):674-81. PubMed ID: 24690772
[TBL] [Abstract][Full Text] [Related]
28. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro.
Wang JS; DeVane CL
Drug Metab Dispos; 2003 Jun; 31(6):742-7. PubMed ID: 12756206
[TBL] [Abstract][Full Text] [Related]
29. Reviewing the mechanisms of natural product-drug interactions involving efflux transporters and metabolic enzymes.
Feltrin C; Oliveira Simões CM
Chem Biol Interact; 2019 Dec; 314():108825. PubMed ID: 31553897
[TBL] [Abstract][Full Text] [Related]
30. Mechanism-based inhibition of CYP3A4 and CYP2D6 by Indonesian medicinal plants.
Subehan ; Usia T; Iwata H; Kadota S; Tezuka Y
J Ethnopharmacol; 2006 May; 105(3):449-55. PubMed ID: 16414224
[TBL] [Abstract][Full Text] [Related]
31. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.
Gurley BJ; Swain A; Hubbard MA; Williams DK; Barone G; Hartsfield F; Tong Y; Carrier DJ; Cheboyina S; Battu SK
Mol Nutr Food Res; 2008 Jul; 52(7):755-63. PubMed ID: 18214849
[TBL] [Abstract][Full Text] [Related]
32. Aloe vera juice: IC₅₀ and dual mechanistic inhibition of CYP3A4 and CYP2D6.
Djuv A; Nilsen OG
Phytother Res; 2012 Mar; 26(3):445-51. PubMed ID: 21842479
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the impact of cantharidin on rat CYP enzymes by using a cocktail of probe drugs.
Zhou CJ; Qiao LM; Zhao LH; Li ZY
Fitoterapia; 2015 Dec; 107():49-53. PubMed ID: 26498206
[TBL] [Abstract][Full Text] [Related]
34. In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.
Habenschus MD; Moreira FL; Lopes NP; de Oliveira ARM
Planta Med; 2017 May; 83(8):727-736. PubMed ID: 28073119
[TBL] [Abstract][Full Text] [Related]
35. Absence of herb-drug interactions of mistletoe with the tamoxifen metabolite (E/Z)-endoxifen and cytochrome P450 3A4/5 and 2D6 in vitro.
Weissenstein U; Kunz M; Oufir M; Wang JT; Hamburger M; Urech K; Regueiro U; Baumgartner S
BMC Complement Altern Med; 2019 Jan; 19(1):23. PubMed ID: 30658716
[TBL] [Abstract][Full Text] [Related]
36. Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes.
Tang L; Ye L; Lv C; Zheng Z; Gong Y; Liu Z
Toxicol Lett; 2011 Apr; 202(1):47-54. PubMed ID: 21277363
[TBL] [Abstract][Full Text] [Related]
37. Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells.
Kumar S; Bouic PJ; Rosenkranz B
J Ethnopharmacol; 2021 Apr; 270():113766. PubMed ID: 33395575
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
Swaisland HC; Ranson M; Smith RP; Leadbetter J; Laight A; McKillop D; Wild MJ
Clin Pharmacokinet; 2005; 44(10):1067-81. PubMed ID: 16176119
[TBL] [Abstract][Full Text] [Related]
39. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
Fasinu PS; Bouic PJ; Rosenkranz B
Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
[TBL] [Abstract][Full Text] [Related]
40. Effect of Trigonella foenum-graecum L. on Metabolic Activity of CYP2D6 and CYP3A4.
Al-Jenoobi FI; Al-Thukair AA; Alam MA; Abbas FA; Al-Mohizea AM; Alkharfy KM; Al-Suwayeh SA
Forsch Komplementmed; 2015; 22(3):180-4. PubMed ID: 26335391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
